MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
3.300
-0.120 (-3.51%)
Mar 5, 2026, 4:00 PM EST - Market closed
MDxHealth Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for MDxHealth stock have an average target of 7.67, with a low estimate of 7.00 and a high estimate of 9.00. The average target predicts an increase of 132.42% from the current stock price of 3.30.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 23, 2025.
Analyst Ratings
The average analyst rating for MDxHealth stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +112.12% | Dec 23, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $5 → $7 | Strong Buy | Maintains | $5 → $7 | +112.12% | Nov 13, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $7 → $9 | Strong Buy | Maintains | $7 → $9 | +172.73% | Nov 13, 2025 |
| BTIG | BTIG | Strong Buy Maintains $6 → $7 | Strong Buy | Maintains | $6 → $7 | +112.12% | Nov 13, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $8 → $6 | Buy | Maintains | $8 → $6 | +81.82% | Nov 7, 2024 |
Financial Forecast
Revenue This Year
140.57M
from 107.88M
Increased by 30.31%
Revenue Next Year
166.40M
from 140.57M
Increased by 18.38%
EPS This Year
-0.40
from -0.67
EPS Next Year
-0.11
from -0.40
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 147.0M | 173.7M | ||
| Avg | 140.6M | 166.4M | ||
| Low | 132.3M | 157.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 36.3% | 23.5% | ||
| Avg | 30.3% | 18.4% | ||
| Low | 22.6% | 12.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.21 | 0.05 | |
| Avg | -0.40 | -0.11 | |
| Low | -0.57 | -0.26 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.